foundayo
Volume band from our last ≈0.2h of snapshots (12 checks) — not a Google Trends screenshot.
Volumes and “searches / hour” are estimates derived from Google Trends public volume bands — not exact live headcounts. How we calculate →
Spike window
First seen on our charts: 2026-11-17. Last on the live AU chart: 2026-11-17.
Momentum: Stable
Stable means volume is holding steady versus recent checks.
What is this?
Orforglipron, sold under the brand name Foundayo, is a medication used for weight management.
Why it's trending
Related headlines currently associated with this spike include "New Wegovy pill v Eli Lilly’s weight-loss tablet: How the GLP-1 pills compare in Australia"; "Second weight-loss pill to be sold in Australia within days"; "TGA approves first-of-its-kind GLP-1 weight loss pill Foundayo for Australian use". Those stories are the strongest public signal for why "foundayo" is trending in Australia right now — we do not invent match results or unverified claims beyond the headline wording.
- New Wegovy pill v Eli Lilly’s weight-loss tablet: How the GLP-1 pills compare in Australia
- Second weight-loss pill to be sold in Australia within days
- TGA approves first-of-its-kind GLP-1 weight loss pill Foundayo for Australian use
How to use it
- Lead with timely explainers, roundups, or reaction content — low commercial intent topics usually reward speed and clarity over hard sell.
- Capture long-tail SEO around “what happened”, timelines, and FAQ-style pages before the spike cools.
- Build a “what we know / what’s next” article that cites the live headlines and updates as coverage changes — freshness is the moat on news-led spikes.
- Package the trend for newsletters or social with a clear hook: who/what it is, why volume jumped, and one actionable next step for your audience.
Related news
Track this keyword
Get a lightweight alert request on file when you want to follow “foundayo” — useful if you arrived from social and want to come back.
We store your email + this keyword on our server so we can build alerts later. No spam list. Or contact us.
All live rates are estimates from Google Trends public feeds. Learn more. Share weekly winners via the weekly roundup.